Jazz Pharmaceuticals
FDA Approves Vyxeos for 2 Types of AML
The FDA approved Vyxeos, Jazz Pharmaceuticals)to treat adults with two types of acute myeloid leukemia (AML): newly ...
AUGUST 4, 2017
FDA Approves First Treatment for Hepatic Veno-Occlusive Disease
First and only FDA-approved therapy for patients with this rare, potentially fatal complication.
MARCH 30, 2016
Load more